Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha.
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Cytokines are now recognized to play important roles in the physiology of the central nervous system (CNS) during health and disease. Tumor necrosis factor alpha (TNF-alpha) has been implicated in the pathogenesis of several human CNS disorders including multiple sclerosis, AIDS dementia, and cerebral malaria. We have generated transgenic mice that constitutively express a murine TNF-alpha transgene, under the control of its own promoter, specifically in their CNS and that spontaneously develop a chronic inflammatory demyelinating disease with 100% penetrance from around 3-8 weeks of age. High-level expression of the transgene was seen in neurons distributed throughout the brain. Disease is manifested by ataxia, seizures, and paresis and leads to early death. Histopathological analysis revealed infiltration of the meninges and CNS parenchyma by CD4+ and CD8+ T lymphocytes, widespread reactive astrocytosis and microgliosis, and focal demyelination. The direct action of TNF-alpha in the pathogenesis of this disease was confirmed by peripheral administration of a neutralizing anti-murine TNF-alpha antibody. This treatment completely prevented the development of neurological symptoms, T-cell infiltration into the CNS parenchyma, astrocytosis, and demyelination, and greatly reduced the severity of reactive microgliosis. These results demonstrate that overexpression of TNF-alpha in the CNS can cause abnormalities in nervous system structure and function. The disease induced in TNF-alpha transgenic mice shows clinical and histopathological features characteristic of inflammatory demyelinating CNS disorders in humans, and these mice represent a relevant in vivo model for their further study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Purification of Mouse Immunoglobulin Heavy‐Chain Messenger RNAs from Total Myeloma Tumor RNA
AUFFRAY, C., & ROUGEON, F. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb06030.x · Cited by 2,627
The Pathophysiology Of Tumor Necrosis Factors
VASSALLI, P. (1992) · Annual Review of Immunology · doi:10.1146/annurev.immunol.10.1.411 · Cited by 1,920
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,660
Self-citationMolecular profile of reactive astrocytes—Implications for their role in neurologic disease
Eddleston, M., & Mucke, L. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90380-x · Cited by 1,431
Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
Selmaj, K. W., & Raine, C. S. (1988) · Annals of Neurology · doi:10.1002/ana.410230405 · Cited by 1,368
Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs.
Brinster, R. L., Chen, H. Y., Trumbauer, M. E., Yagle, M. K., & Palmiter, R. D. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.13.4438 · Cited by 1,027
The T Lymphocyte In Experimental Allergic Encephalomyelitis
Zamvil, S. (1990) · Annual Review of Immunology · doi:10.1146/annurev.immunol.8.1.579 · Cited by 1,009
Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.
Campbell, I. L., Abraham, C. R., Masliah, E., Kemper, P., Inglis, J. D., Oldstone, M. B., & Mucke, L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10061 · Cited by 1,006
Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90746-3 · Cited by 986
Cytokines and the nervous system II: actions and mechanisms of action
Rothwell, N. J., & Hopkins, S. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93890-a · Cited by 923
Cited by
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Tumor necrosis factor signaling
Wajant, H., Pfizenmaier, K., & Scheurich, P. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401189 · Cited by 2,359
Pasparakis, M., Alexopoulou, L., Episkopou, V, & Kollias, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1397 · Cited by 1,160
Self-citationBrain Inflammation in Epilepsy: Experimental and Clinical Evidence
Vezzani, A., & Granata, T. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00298.x · Cited by 1,036
Fibrinogen as a key regulator of inflammation in disease
Davalos, D., & Akassoglou, K. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0290-8 · Cited by 922
Self-citationMcCoy, M. K., & Tansey, M. G. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-45 · Cited by 847
Inflammatory processes in Alzheimer's disease
Heneka, M. T., & O'Banion, M. K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.017 · Cited by 782
“Further support for a more cytopathic role of these molecules comes from transgenic animal experiments showing that mice expressing these inflammatory proteins under brain-specific promoters invariably exhibit profound pathologic changes (Probert et al., 1995; Stalder et al., 1998; Wyss-Coray et al., 1995, 1997).”
Interrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF
Fischer, R., & Maier, O. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/610813 · Cited by 731
Cardiac Failure in Transgenic Mice With Myocardial Expression of Tumor Necrosis Factor-α
Bryant, D., Becker, L., Richardson, J., Shelton, J., Franco, F., Peshock, R., Thompson, M., & Giroir, B. (1998) · Circulation · doi:10.1161/01.cir.97.14.1375 · Cited by 600
The role of cytokines in the pathophysiology of epilepsy
Vezzani, A., Balosso, S., & Ravizza, T. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.03.009 · Cited by 558
Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis
Benveniste, E. N. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050101 · Cited by 533
TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects
Probert, L. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.038 · Cited by 495
Self-citationCNS inflammation and neurodegeneration
Chitnis, T., & Weiner, H. L. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90609 · Cited by 470
A quantitative analysis of oligodendrocytes in multiple sclerosis lesions
Lucchinetti, C., Brück, W., Parisi, J., Scheithauer, B., Rodriguez, M., & Lassmann, H. (1999) · Brain · doi:10.1093/brain/122.12.2279 · Cited by 464
Neuroinflammatory processes in Alzheimer’s disease
Heneka, M. T., O’Banion, M. K., Terwel, D., & Kummer, M. P. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0438-z · Cited by 433
“…support for a more cytopathic role of these molecules comes from transgenic animal experiments showing that mice expressing these inflammatory proteins under brain-specific promoters invariably exhibit profound pathologic changes (Probert et al. 1995; Stalder et al. 1998; Wyss-Coray et al. 1997).”
BackgroundMarchetti, L., Klein, M., Schlett, K., Pfizenmaier, K., & Eisel, U. L. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311766200 · Cited by 427
Lafaille, J. J., Keere, F. V. D., Hsu, A. L., Baron, J. L., Haas, W., Raine, C. S., & Tonegawa, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.307 · Cited by 426
Role of TNF–TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications
Yang, S., Wang, J., Brand, D. D., & Zheng, S. G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00784 · Cited by 410
Crews, F. T., Bechara, R., Brown, L. A., Guidot, D. M., Mandrekar, P., Oak, S., Qin, L., Szabo, G., Wheeler, M., & Zou, J. (2006) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00084.x · Cited by 406
Pathology of Demyelinating Diseases
Popescu, B. F. G., & Lucchinetti, C. F. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132443 · Cited by 397
Inflammatory cytokines in the pathogenesis of periventricular leukomalacia
Kadhim, H., Tabarki, B., Verellen, G., De Prez, C., Rona, A.-M., & Sébire, G. (2001) · Neurology · doi:10.1212/wnl.56.10.1278 · Cited by 396
Angeles Muñoz-Fernández, M., & Fresno, M. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00045-8 · Cited by 367
Montgomery, S. L., & Bowers, W. J. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9287-2 · Cited by 366
Bartholdi, D., & Schwab, M. E. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01497.x · Cited by 357
Rezaie, P., & Dean, A. (2002) · Neuropathology · doi:10.1046/j.1440-1789.2002.00438.x · Cited by 332
Akassoglou, K., Bauer, J., Kassiotis, G., Pasparakis, M., Lassmann, H., Kollias, G., & Probert, L. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65622-2 · Cited by 316
Self-citationNegi, G., Kumar, A., & Sharma, S. S. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00821.x · Cited by 314
Robinson, W. H., Genovese, M. C., & Moreland, L. W. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200109)44:9<1977::aid-art345>3.0.co;2-6 · Cited by 310
Salim, S., Chugh, G., & Asghar, M. (2012) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/b978-0-12-398314-5.00001-5 · Cited by 310
Neuropathology in multiple sclerosis: new concepts
Lassmann, H. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400301 · Cited by 306
Astrocytes—Friends or foes in multiple sclerosis?
Williams, A., Piaton, G., & Lubetzki, C. (2007) · Glia · doi:10.1002/glia.20546 · Cited by 302
Perinatal brain injury in the preterm and term newborn
du Plessis, A. J., & Volpe, J. J. (2002) · Current Opinion in Neurology · doi:10.1097/00019052-200204000-00005 · Cited by 295
Ben-Hur, T., Ben-Menachem, O., Furer, V., Einstein, O., Mizrachi-Kol, R., & Grigoriadis, N. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00218-5 · Cited by 284
Minocycline as a Neuroprotective Agent
Stirling, D. P., Koochesfahani, K. M., Steeves, J. D., & Tetzlaff, W. (2005) · The Neuroscientist · doi:10.1177/1073858405275175 · Cited by 279
Li, G., Bauer, S., Nowak, M., Norwood, B., Tackenberg, B., Rosenow, F., Knake, S., Oertel, W. H., & Hamer, H. M. (2011) · Seizure · doi:10.1016/j.seizure.2010.12.005 · Cited by 274
Inflammation in epileptogenesis after traumatic brain injury
Webster, K. M., Sun, M., Crack, P., O’Brien, T. J., Shultz, S. R., & Semple, B. D. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0786-1 · Cited by 274
Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis
Steinman, L., & Zamvil, S. S. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.08.014 · Cited by 265
Kollias, G., Douni, E., Kassiotis, G., & Kontoyiannis, D. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01315.x · Cited by 263
Self-citationIto, A., Bebo, B. F., Matejuk, A., Zamora, A., Silverman, M., Fyfe-Johnson, A., & Offner, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.542 · Cited by 254
Wagner, R., Janjigian, M., & Myers, R. R. (1998) · Pain · doi:10.1016/s0304-3959(97)00148-6 · Cited by 253
The role of cytokines and growth factors in seizures and their sequelae
Jankowsky, J. L., & Patterson, P. H. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00022-8 · Cited by 238
Michlewska, S., Dransfield, I., Megson, I. L., & Rossi, A. G. (2009) · The FASEB Journal · doi:10.1096/fj.08-121228 · Cited by 225
Cytokines in multiple sclerosis: from bench to bedside
IMITOLA, J., CHITNIS, T., & KHOURY, S. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.11.007 · Cited by 215
Kollias, G., Douni, E., Kassiotis, G., & Kontoyiannis, D. (1999) · Annals of the Rheumatic Diseases · doi:10.1136/ard.58.2008.i32 · Cited by 210
Self-citationEpilepsy and Inflammation in the Brain: Overview and Pathophysiology
Vezzani, A. (2014) · Epilepsy Currents · doi:10.5698/1535-7511-14.s2.3 · Cited by 208
Küsters, S., Tiegs, G., Alexopoulou, L., Pasparakis, M., Douni, E., Künstle, G., Bluethmann, H., Wendel, A., Pfizenmaier, K., Kollias, G., et al. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271119 · Cited by 176
Self-citationTNF-α transgenic and knockout models of CNS inflammation and degeneration
Probert, L., Akassoglou, K., Kassiotis, G., Pasparakis, M., Alexopoulou, L., & Kollias, G. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00184-1 · Cited by 167
Self-citationMadsen, P. M., Motti, D., Karmally, S., Szymkowski, D. E., Lambertsen, K. L., Bethea, J. R., & Brambilla, R. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.0211-16.2016 · Cited by 161
Berard, J. L., Wolak, K., Fournier, S., & David, S. (2010) · Glia · doi:10.1002/glia.20935 · Cited by 147
“Previous work has demonstrated that TNFa can promote demyelination and oligodendrocyte apoptosis (Probert et al., 1995), while IL-1a has been shown”
BackgroundPatel, J. R., Williams, J. L., Muccigrosso, M. M., Liu, L., Sun, T., Rubin, J. B., & Klein, R. S. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1034-0 · Cited by 134
“In addition, transgenic mice that over-express TNF-a spontaneously develop chronic, inflammatory demyelinating disease [45].”
BackgroundInfiltrating Macrophages Are Key to the Development of Seizures following Virus Infection
Cusick, M. F., Libbey, J. E., Patel, D. C., Doty, D. J., & Fujinami, R. S. (2013) · Journal of Virology · doi:10.1128/jvi.02747-12 · Cited by 112
Blood-brain barrier hyperpermeability precedes demyelination in the cuprizone model
Berghoff, S. A., Düking, T., Spieth, L., Winchenbach, J., Stumpf, S. K., Gerndt, N., Kusch, K., Ruhwedel, T., Möbius, W., & Saher, G. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0497-6 · Cited by 100
“Does an impaired BBB directly affect the course of demyelinating disease? Chronic upregulation of inflammatory mediators directly impairs BBB integrity and can induce demyelinating pathology [46]; conversely, their genetic or pharmacological reduction can improve BBB function but their role in modulating severity of d…”
An overall view of the most common experimental models for multiple sclerosis
Dedoni, S., Scherma, M., Camoglio, C., Siddi, C., Dazzi, L., Puliga, R., Frau, J., Cocco, E., & Fadda, P. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106230 · Cited by 79
Zhang, N., Wang, Z., & Zhao, Y. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.03.002 · Cited by 72
Cowan, E. P., Alexander, R. K., Daniel, S., Kashanchi, F., & Brady, J. N. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6982-6989.1997 · Cited by 63
Astroglial‐derived lymphotoxin‐α exacerbates inflammation and demyelination, but not remyelination
Plant, S. R., Arnett, H. A., & Ting, J. P. (2005) · Glia · doi:10.1002/glia.20089 · Cited by 60
“Transgenic mice overexpressing TNF in the brain demonstrate spontaneous demyelinating disease, which is dependent on signaling via TNF receptor 1 (Probert et al., 1995; Akassoglou et al., 1998).”
BackgroundPurinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy
Oliveira-Giacomelli, Á., Naaldijk, Y., Sardá-Arroyo, L., Gonçalves, M. C. B., Corrêa-Velloso, J., Pillat, M. M., de Souza, H. D. N., & Ulrich, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00325 · Cited by 50
“It has been previously demonstrated that constant presence of high TNF-α levels can induce demyelination in a similar way as observed in MS patients, indicating that dysregulation of TNFα by A1 receptors can be an initiating factor for MS pathology (Probert et al., 1995).”
ResultSelective serotonin reuptake inhibitors and inflammatory bowel disease; Beneficial or malpractice
Hatamnejad, M. R., Baradaran Ghavami, S., Shirvani, M., Asghari Ahmadabad, M., Shahrokh, S., Farmani, M., Sherkat, G., Asadzadeh Aghdaei, H., & Zali, M. R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.980189 · Cited by 28
“declared that anti-depressants could increase intracellular cAMP (103) in microglia and macrophages, alleviating pro-inflammatory cytokines (104, 105).”
BackgroundZhou, X., Chen, J., Tao, H., Cai, Y., Huang, L., Zhou, H., Chen, Y., Cui, L., Zhong, W., & Li, K. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s247677 · Cited by 26
Metadata
- Authors
- Probert, L., Akassoglou, K., Pasparakis, M., Kontogeorgos, G., & Kollias, G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1995-11-21
- Volume
- 92
- Issue
- 24
- Pages
- 11294-11298
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2083881390
- Cited by
- 403
- References
- 52
- FWCI
- 15.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.